1 |
Nakagami H. Mechanisms underlying the bidirectional association between nonalcoholic fatty liver disease and hypertension. Hypertens Res 2023;46:539-41. [PMID: 36474031 DOI: 10.1038/s41440-022-01117-6] [Reference Citation Analysis]
|
2 |
Fu CE, Yong JN, Ng CH, Nah B, Chew NWS, Chin YH, Kong G, Tan DJH, Lim WH, Lim LKE, Zeng RW, Shabbir A, Tan EXX, Huang DQ, Khoo CM, Siddqui MS, Chan MYY, Noureddin M, Mamas MA, Muthiah M. Original article: The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome. Aliment Pharmacol Ther 2023. [PMID: 36710531 DOI: 10.1111/apt.17397] [Reference Citation Analysis]
|
3 |
Di Bonito P, Di Sessa A, Licenziati MR, Corica D, Wasniewska M, Umano GR, Morandi A, Maffeis C, Faienza MF, Mozzillo E, Calcaterra V, Franco F, Maltoni G, Valerio G. Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD? Children 2023;10:233. [DOI: 10.3390/children10020233] [Reference Citation Analysis]
|
4 |
Fu H, Yu H, Zhao Y, Chen J, Liu Z. Association Between Hypertension and the Prevalence of Liver Steatosis and Fibrosis.. [DOI: 10.21203/rs.3.rs-2400318/v1] [Reference Citation Analysis]
|
5 |
Ng CH, Xiao J, Chew NWS, Chin YH, Chan KE, Quek J, Lim WH, Tan DJH, Loke RWK, Tan C, Tang ASP, Goh XL, Nah B, Syn N, Young DY, Tamaki N, Huang DQ, Siddiqui MS, Noureddin M, Sanyal A, Muthiah M. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality. Front Med (Lausanne) 2022;9:985803. [PMID: 36275825 DOI: 10.3389/fmed.2022.985803] [Reference Citation Analysis]
|
6 |
Ng CH, Nah B, Kaewdech A, Aung HB, Mak L, Kulkarni AV, Muthiah M. Factors Associated with Risk of NAFLD and Progression in Multiethnic Asians. A Latent Class and Machine Learning Analysis.. [DOI: 10.21203/rs.3.rs-1968295/v1] [Reference Citation Analysis]
|